Navigation Links
Historic Breakthrough in Fighting Children's Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
Date:1/30/2008

BEIJING, Jan. 30 /Xinhua-PRNewswire/ -- Tiantan Puhua Hospital Stem Cells Center ( http://www.stemcellspuhua.com ), the worldwide leader in using stem cells to effectively treat Parkinson's and other neurological diseases, announced another historic first in successfully using stem cells to improve and potentially prolong the life of 6 year old California native Blake Dell'Aringa. Blake was a normal, happy toddler until last year when diagnosed in America with what has been widely thought an untreatable genetic disorder occurring primarily in children called "Batten Disease". Due to a missing gene, the disease causes sudden, rapid degeneration of the nervous system and always ends in premature fatality, often between the ages of 6 and 12. After undergoing Tiantan Puhua's comprehensive stem cell therapy program in Beijing, Blake's family is now reporting a significant reversal in the recent swift deterioration of Blake's motor skills, giving real hope that he will live long enough for a scientific cure to be found. More on Blake can be found at http://www.stemcellspuhua.com/s71.html .

Blake's mother Dawn said, "Our world was just rocked when Blake was diagnosed with Batten Disease. Now, every second of his life is meaningful to us. Going all the way to China wasn't our first choice, but it was almost our only choice and definitely the right one as Blake has had clear improvement since he's returned. Every day he's stronger and stronger than before. Tiantan Puhua has given Blake real hope."

Blake's parents decided to bring him to Beijing after first being allowed to participate, but then later rejected just days before commencing treatment, in one of America's only federally authorized stem cell trials in the State of Oregon. As is often the case in the West, patients like Blake can be blocked or delayed for political reasons when seeking stem cell treatment for life threatening illnesses in their home countries.

Blake's stepfather Jeremy Jaeger, who accompanied him to Beijing said, "Stem cells in America can be very political, but I really don't understand or even care so much about that. My only concern is in providing the absolute best care in the world for Blake and ensuring he gets what he deserves. Everyone in China was so great to us and we are really glad we went."

Blake's mother Dawn, who remained in California for the two months of Blake's stem cell therapy in Beijing, was amazed to see distinct improvements upon his return. Since Blake's return to California, she reports that his hands are unclenched and are no longer spastic. Blake now has his grip back and is clapping his hands. As well, after the treatment, Blake is holding his head up about 90% of the time compared with only 40% before. Cognitively Blake has also become more alert and is smiling more often, while attempting much more communication with his mother and father.

More on Blake's improvements after his return from china can be found on his blog at: http://www.blakespurpose.org .

Batten Disease is named after the British pediatrician who first described it in 1903. Also known as Spielmeyer-Vogt-Sjogren-Batten Disease, it is the most common form of a group of disorders called Neuronal Ceroid Lipofuscinoses, or NCLs. Due to a genetic defect at birth, over time those with NCL suffer progressive nervous system breakdown leading to mental impairment, worsening seizures, increasing loss of sight and motor skills until shortly before death they become blind, bedridden, suffer dementia, and are incommunicable. Although Batten Disease is usually regarded as the juvenile form of NCL, it has now become the term to encompass all forms of NCL.

Blake suffers from Late Infantile NCL, (Jansky-Bielschowsky Disease), which begins between ages 2 and 4. This form progresses rapidly and always ends in death sometime between ages 8 and 12. The typical early signs of this type of NCL are loss of muscle coordination known as ataxia and seizures, along with progressive mental deterioration. Blake has suffered all these symptoms in the past year. Batten Disease/NCL as a whole is relatively rare worldwide, occurring in an estimated 2 to 4 of every 100,000 births in the United States according to several sources. Currently, there is widespread belief in global medical circles that premature death from this life-limiting disease is non-preventable. Tiantan Puhua Hospital has once again proved that its cutting edge stem cell therapy and comprehensive professional medical care can prolong and improve the life of patients suffering from previously thought untreatable nervous system disorders.

"When considering all options in the US and globally for Blake, I realized that Tiantan Puhua Hospital was the most qualified place to turn to due to the rational price of the procedure and treatment. After experiencing the wonderful level of care from everyone in China, I know we were right to choose Beijing. We are considering a second trip back," said Jeremy Jaeger.

About Tiantan Puhua Neurosurgical Hospital

Tiantan (Temple of Heaven) Puhua Neurosurgical Hospital, a Hospital under TP Biomedical Ltd., is a world-class neurological treatment facility in Beijing that is gaining renown as the world's foremost center for treatment of Parkinson's disease, brain injury, and a range of other neurological disorders through its groundbreaking stem cell therapy. The Hospital collaborates with the Stem Cells Research Center of Peking University, which is the foremost stem cells research center in China. There, stem cells are cultured for clinical application. To date, Tiantan Puhua Hospital has treated with stem cells over 60 international patients suffering from a range of neurological disorders. More details about Tiantan Puhua Hospital can be found on the website http://www.stemcellspuhua.com .

For more information, please contact:

Dr. Sherwood Yang -- Vice President,

Tiantan Puhua Neurosurgical Hospital

Tiantan Nanli, Beijing 100050, CHINA

International Department

Tel: +86-156-0103-0031

Email: kotan@stemcellspuhua.com

vivian@stemcellspuhua.com

More information can also be found on China's leading stem cells news site: http://www.stemcellschina.com


'/>"/>
SOURCE Tiantan Puhua Hospital Stem Cells Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welchs
2. Breakthrough Opportunity for Improving Patient Health
3. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
4. The Wisconsin Heart Hospital Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
5. Panacea Pharmaceuticals Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazines Ten Biggest Medical Breakthroughs of 2007
6. Stem Cell Breakthrough Could End Human Embryonic Experimentation
7. Discovery Institute Bioethicist Lauds Breakthrough in Stem Cells Research that Eliminates Need for Human Cloning
8. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
9. Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus
10. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
11. Breakthrough research identifies how cells from pigs may cure diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... 2017  Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, announced ... showed that aerosolized KL4 surfactant reduced lung inflammation ... animal model. The Company believes that these preclinical ... that supports the role of KL4 surfactant as ...
(Date:2/16/2017)... LAFAYETTE, Indiana (PRWEB) , ... ... ... division of Albany Molecular Research Inc. has further extended its industry leading ... This service offers state-of-the-art cGMP techniques and methods for the ...
Breaking Biology Technology:
(Date:1/24/2017)... Jan. 24, 2017  It sounds simple and ... that monitors vital signs and alerts parents on ... oxygen saturation level drops. But pediatric experts argue ... parents, with no evidence of medical benefits, especially ... marketed aggressively to parents of healthy babies, promising ...
(Date:1/19/2017)... , Jan. 19, 2017 Sensory ... experience and security for consumer electronics, and ... processing systems and cybersecurity solutions, today announced a ... and financial institutions worldwide to bolster security of ... end-to-end secure user authentication platforms they offer, innerCore ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
Breaking Biology News(10 mins):